Core Viewpoint - The meeting held by the Central Committee of the Democratic Progressive Party (民进中央) emphasizes the importance of enhancing self-construction and fulfilling responsibilities in line with the overall situation, particularly in preparation for the 2026 "14th Five-Year Plan" [2]. Group 1: Proposals and Focus Areas - The Central Committee received 567 proposal materials this year and plans to submit 74 proposals to the conference, with 46 submitted under the name of the Central Committee and 28 under the name of the democratic party [2]. - The proposals will focus on various fields including education, culture, publishing and media, technology and healthcare, economy, population resources and environment, and social law [2]. Group 2: Specific Areas of Focus - In the education sector, 11 proposals will address issues such as enhancing integrated services for early childhood education, promoting balanced development of compulsory education in western regions, and improving the support system for young scientific talent [2]. - The culture sector will have 4 proposals focusing on the prosperity of new mass arts under internet conditions and the protection of revolutionary cultural heritage [3]. - The publishing and media sector will have 2 proposals aimed at accelerating the development of top-tier Chinese journals and strengthening language governance in cyberspace [4]. - The technology and healthcare sector will have 8 proposals, including promoting AI in healthcare and improving the financial support mechanism for major scientific tasks [4]. - The economy sector will have 8 proposals focusing on establishing mechanisms to prevent poverty, promoting green industry development, and addressing the impact of AI on the job market [4]. - The population resources and environment sector will have 8 proposals, including strengthening wetland protection in the Yellow River basin and advancing the national carbon market [6]. - The social and legal sector will have 5 proposals aimed at promoting new employment forms and improving the management system for intellectual property [6].

Group 1 - The core point of the article highlights that southbound funds reduced their holdings in iFlytek Medical Technology (02506.HK) by 4,000 shares on February 26 [1] - Over the past five trading days, there were three days of net increases in southbound fund holdings, totaling an increase of 85,800 shares [1] - In the last twenty trading days, there were ten days of net increases in southbound fund holdings, amounting to a total increase of 57,900 shares [1] Group 2 - As of now, southbound funds hold 5,207,200 shares of iFlytek Medical Technology, which represents 6.73% of the company's total issued ordinary shares [1] - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services, hospital services, patient services, and regional management platform solutions [1]

Core Viewpoint - The southbound capital has increased its holdings in iFlytek Medical Technology (02506.HK), indicating growing investor interest in the company, particularly in the context of its AI-enabled healthcare solutions [1][2]. Group 1: Shareholding Changes - On February 6, 2026, southbound capital increased its holdings by 75,200 shares, representing a 1.40% increase [2]. - Over the past five trading days, there were two days of net increases, totaling 140,300 shares [1]. - In the last 20 trading days, there were 12 days of net increases, amounting to 1,661,200 shares [1]. Group 2: Current Shareholding Status - As of February 6, 2026, southbound capital holds 5,437,800 shares of iFlytek Medical Technology, which accounts for 7.02% of the company's total issued ordinary shares [1][2]. Group 3: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-enabled healthcare solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2].

Core Viewpoint - Recent trading activity indicates a reduction in holdings by southbound funds in iFlytek Medical Technology, suggesting potential shifts in investor sentiment towards the company [1] Group 1: Trading Activity - On December 22, southbound funds reduced their holdings by 40,900 shares of iFlytek Medical Technology (02506.HK) [1] - Over the past five trading days, there have been four days of net reductions, totaling 107,900 shares [1] - In the last 20 trading days, there were 14 days of net increases, with a total of 91,600 shares added [1] - Currently, southbound funds hold 3,978,600 shares of iFlytek Medical Technology, representing 5.14% of the company's issued ordinary shares [1] Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [1] - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-diagnosis management) [1] - The company also offers regional management platform solutions, including smart health solutions and smart medical insurance [1] - iFlytek Medical Technology mainly operates in the domestic market [1]

Core Insights - The eighth "Shanghai Medical Reform Top Ten Innovative Measures" was announced, with a record 142 initiatives submitted from 122 medical institutions since the selection process began in March [1] - The final ten award-winning projects were selected from an initial 47 shortlisted initiatives after expert evaluation and public voting [1] Group 1: Award-Winning Initiatives - Emergency multidisciplinary collaboration to strengthen the life defense line for critically ill patients [1] - Establishing a new paradigm for collaboration between traditional Chinese and Western medicine to enhance healthcare service quality [1] - Creating a "popular science cradle" for maternal and child health in the new era, focusing on prevention [1] Group 2: Nomination Awards - Comprehensive implementation of priority outpatient appointment resources from secondary and tertiary hospitals to grassroots healthcare, supporting the tiered diagnosis and treatment system [2] - Empowering commercial insurance development through multi-payment methods and exploring the "Shanghai model" for direct compensation between medical insurance and commercial insurance [2] - Enhancing the quality and efficiency of clinical trials to facilitate the research and market entry of innovative drugs [2] - Utilizing artificial intelligence in internet hospitals to support tiered diagnosis and treatment, improving healthcare supply and patient experience [2] - Implementing comprehensive strategies for prevention, treatment, management, and rehabilitation to strengthen the mental health defense line for citizens [2] - Innovating community pharmacy services within a "15-minute community living circle" through digital empowerment of pharmaceutical services [2] - Building oral specialty medical alliances to practice high-quality, efficient, and collaborative integrated tiered diagnosis and treatment services [2] - Focusing on new specialty (disease) breakthroughs to collectively promote the effective implementation of the "strong waist" action in district public hospitals [2] - Ensuring high-quality development of rehabilitation medical services through smart medical data [2] - Leveraging medical statistical data to empower health insurance services, meeting diverse health service needs of the public [2]

Core Viewpoint - Southbound funds increased their holdings in iFlytek Medical Technology (02506.HK) by 650.0 shares on November 17, 2025, while experiencing a net reduction of 4,500.0 shares over the past five trading days [1][2]. Group 1: Southbound Fund Activity - In the last 20 trading days, iFlytek Medical Technology saw 12 days of net increases in southbound fund holdings, totaling 82,600 shares [1]. - As of November 17, 2025, southbound funds hold 3.7932 million shares of iFlytek Medical Technology, representing 4.9% of the company's total issued ordinary shares [1][2]. Group 2: Company Overview - iFlytek Medical Technology is primarily engaged in providing AI-powered medical solutions in China, with business lines including grassroots medical services, hospital services, patient services, and regional management platform solutions [2]. - The grassroots medical services line consists of intelligent medical assistants and chronic disease management, while the hospital services line includes smart hospital solutions and diagnostic assistance [2]. - Patient services encompass smart hospital patient services, post-discharge management, imaging cloud platforms, and medical devices [2].

Core Viewpoint - Southbound funds reduced their holdings in iFlytek Medical Technology (02506.HK) by 5,550 shares on October 16, 2025, indicating a slight decrease in investor confidence in the short term [1]. Group 1: Southbound Fund Activity - In the last five trading days, southbound funds increased their holdings on three days, with a total net increase of 85,400 shares [1]. - Over the past 20 trading days, there were 16 days of net increases, totaling 253,400 shares [1]. - As of now, southbound funds hold 3,710,600 shares of iFlytek Medical Technology, accounting for 4.79% of the company's total issued ordinary shares [1]. Group 2: Company Overview - iFlytek Medical Technology Co., Ltd. primarily provides AI-enabled medical solutions in China [2]. - The company's business lines include grassroots medical services (intelligent medical assistants and chronic disease management), hospital services (smart hospital solutions and diagnostic assistants), and patient services (smart hospital patient services and post-discharge management) [2]. - The regional management platform solutions include smart health solutions and smart medical insurance [2].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦不發表 任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何 責任。 最新業務進展 本公告乃由雲知聲智能科技股份有限公司（「本公司」）自願作出，旨在知會本公司股東 及潛在投資者有關本公司的最新業務發展情況。 UNISOUND AI TECHNOLOGY CO., LTD. 雲知聲智能科技股份有限公司 （於中華人民共和國註冊成立的股份有限公司） （股份代號：9678） 自願性公告 於本公告日期，本公司董事會包括：(i)執行董事梁家恩博士、黃偉博士、康恒博士、李霄寒先生、劉升平先生及 李鵬先生；(ii)非執行董事鄺子平先生、李志超先生、汪存富先生及李昂先生；及(iii)獨立非執行董事胡建軍先生、 樊健先生、金慧華女士、張坤博士及陳華先生。 本公司董事會（「董事會」）欣然宣佈，本公司成功中標首都醫科大學北京友誼醫院（「北 京友誼醫院」）AI能力平台等多個智能體（Agent）項目，實現與北京友誼醫院在目前合作 基礎上服務關係的進一步深化，也標誌著本公司在智慧醫療領域的技術落地和商業 ...

Core Viewpoint - The company primarily operates in the domestic market, providing AI-enabled medical solutions, with business lines including primary healthcare services, hospital services, patient services, and regional management platform solutions [5] Revenue and Profit Growth - Historical revenue and net profit growth rates show fluctuations, with a notable increase in revenue growth rate in 2023 compared to previous years [7][10] - The company's revenue for the first half of 2025 is composed of various segments: hospital solutions (0.529 billion), patient management services (1.043 billion), regional solutions (0.576 billion), and primary healthcare solutions (0.838 billion) [9] Financial Performance Metrics - In the first half of 2025, the average return on equity was -8.2%, an increase of 20.62 percentage points from the same period last year [14] - The company's total asset turnover ratio has shown a consistent trend, with a notable value of 0.44 times in 2025H1 [17] Asset and Liability Changes - As of the first half of 2025, significant changes in assets include a 7.7% increase in receivables, a 44.97% increase in long-term receivables, a 28.7% increase in inventory, and a 77.75% increase in contract assets [23] - On the liabilities side, long-term borrowings increased by 224.07%, and short-term borrowings increased by 68.61%, indicating a rise in the proportion of total assets [26] Liquidity Ratios - The company reported a current ratio of 1.60 and a quick ratio of 1.49 in the first half of 2025, indicating a stable liquidity position [29]